Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Trends Cardiovasc Med. 2011 Jan;21(1):1-5. doi: 10.1016/j.tcm.2011.12.009.
The transcriptional enhancer factor (TEF) multigene family is primarily functional in muscle-specific genes through binding to MCAT elements that activate or repress transcription of many genes in response to physiological and pathological stimuli. Among the TEF family, TEF-1, RTEF-1, and DTEF-1 are critical regulators of cardiac and smooth muscle-specific genes during cardiovascular development and cardiac disorders including cardiac hypertrophy. Emerging evidence suggests that in addition to functioning as muscle-specific transcription factors, members of the TEF family may be key mediators of gene expression induced by hypoxia in endothelial cells by virtue of its multidomain organization, potential for post-translational modifications, and interactions with numerous transcription factors, which represent a cell-selective control mediator of nuclear signaling. We review the recent literature demonstrating the involvement of the TEF family of transcription factors in the regulation of differential gene expression in cardiovascular physiology and pathology.
转录增强因子(TEF)基因家族主要通过与 MCAT 元件结合,在肌肉特异性基因中发挥功能,从而激活或抑制许多基因的转录,以响应生理和病理刺激。在 TEF 家族中,TEF-1、RTEF-1 和 DTEF-1 是心血管发育和包括心肌肥厚在内的心脏紊乱过程中心脏和平滑肌特异性基因的关键调节因子。新出现的证据表明,除了作为肌肉特异性转录因子发挥功能外,TEF 家族的成员还可能是内皮细胞缺氧诱导基因表达的关键介质,这是由于其多结构域组织、潜在的翻译后修饰以及与许多转录因子的相互作用,这些都是核信号的细胞选择性控制介质。我们综述了最近的文献,这些文献证明了 TEF 家族转录因子在心血管生理学和病理学中调节差异基因表达中的作用。